ESC

Start typing to search across all content

EU RegulationNational FrameworksAOC/DOC RulesInternational Trade

NBT Grape Regulatory Landscape: Global Status

NBT Grape Regulatory Landscape

The Regulatory Challenge

Gene-edited grapes face a unique regulatory challenge: they must navigate both general biotechnology rules AND appellation/origin regulations. A CRISPR-edited Pinot Noir must be approved both as a “safe” plant AND as acceptable for Burgundy AOC production.

European Union: The Key Battleground

Historical Context

2018 ECJ Ruling: Court of Justice ruled gene-edited organisms ARE GMOs under EU law, triggering strict Directive 2001/18 requirements.

Impact: Effectively blocked NBT development in EU for 5+ years.

2023-2024 Reform

European Commission Proposal: New regulation categorizing NBTs:

Category 1 (Deregulated):

  • ≤20 genetic modifications
  • Changes achievable through conventional breeding
  • No transgenic material
  • Most grape applications would qualify

Category 2 (Light regulation):

  • More extensive modifications
  • Labeling required
  • Simplified risk assessment

Current Status (2026)

  • Parliament and Council negotiations ongoing
  • Expected adoption: 2024-2025
  • Implementation: 2026-2027
  • Member state transposition: Variable

Italy: TEA Framework

2023 Authorization

Landmark legislation: First EU country with clear NBT framework

Key provisions:

  • Open-field trials permitted
  • Scientific committee oversight
  • Defined approval pathway
  • Not classified as GMO (domestically)

Current activities:

  • Multiple grape variety trials
  • Government support
  • Consortium funding

Implications for DOC/DOCG

Question: Can TEA varieties be used in denomination wines?

Current answer: Not yet—requires separate DOC/DOCG rule amendments

Expected timeline: Post-EU regulation finalization

France: Cautious Progress

INRAE Research

Active programs but constrained by EU regulation:

  • Greenhouse research permitted
  • Field trials complex
  • Commercial path unclear

AOC Implications

INAO position: Monitoring developments; no commitment

Champagne: Comité Champagne studying implications

Bordeaux: Cautious interest in Merlot applications

Regulatory Pathway

Waiting for EU clarity before national framework development.

Germany: Scientific Leadership

Julius Kühn-Institut

Strong research capacity:

  • Grapevine genome expertise
  • CRISPR methodology development
  • International collaboration

Regulatory Position

Following EU framework; no separate national provisions.

Industry Interest

German wine industry monitoring; particular interest for:

  • Riesling disease resistance
  • Climate adaptation

Switzerland: Strict Current Stance

Current Law

Gene editing = GMO under Swiss law:

  • No field trials
  • Research limited to contained facilities
  • Commercial use prohibited

Policy Review

Ongoing discussion about NBT regulation:

  • Scientific community advocates change
  • Consumer groups skeptical
  • Referendum possible

Relationship to PIWI

Switzerland may continue PIWI focus while NBT regulatory landscape evolves.

United Kingdom: Post-Brexit Flexibility

2023 Genetic Technology Act

UK diverged from EU:

  • Gene-edited plants NOT classified as GMOs
  • Simplified approval pathway
  • Commercial cultivation possible

Wine Implications

  • English wine could theoretically use NBT varieties
  • Research partnerships with EU complicated
  • First potential NBT wine market

United States: Case-by-Case

USDA-APHIS Approach

SECURE Rule (2020): Streamlined approval for gene-edited plants

Criteria for exemption:

  • Single gene modification
  • Result achievable through conventional breeding
  • No plant pest sequences

Grape Status

Some gene-edited grape research would qualify for exemption:

  • MLO knockouts likely exempt
  • More complex edits case-by-case

Wine Industry Position

Cautious interest; consumer perception concerns.

Australia: Evolving Framework

Current Status

Gene editing regulations under review:

  • Following international developments
  • Industry consultation ongoing

Wine Industry Interest

Australian wine sector monitoring for:

  • Heat tolerance applications
  • Disease resistance

Argentina/Chile: Watch Closely

Positions

  • Generally biotechnology-positive
  • Following international developments
  • Potential early adopters

Wine Industry Scale

Major wine exporters may influence global acceptance.

Appellation Rules: The Second Hurdle

The Core Question

Even if NBT plants are deregulated, can they be used in protected denominations?

Current AOC/DOC Framework

Most appellation rules specify:

  • Permitted grape varieties (by name)
  • Traditional production methods
  • “Customary practices”

Amendment Process

RegionAuthorityProcess
France (AOC)INAONational decree
Italy (DOC/DOCG)MinistryConsortium proposal
Germany (QbA)StatesRegional regulation
Spain (DO)ConsejosApplication to Ministry

Likely Approach

Probable solution: Define NBT varieties as “variants” of traditional variety, not new varieties.

Example: “CRISPR Nebbiolo” = Nebbiolo for DOCG purposes

International Trade Considerations

Export Markets

Key questions:

  • Will importing countries accept NBT wines?
  • Labeling requirements?
  • Traceability systems?

Potential Issues

MarketLikely Position
USAAcceptance likely
UKAcceptance likely
JapanCase-by-case
ChinaUncertain
RussiaResistant

Coexistence Challenge

How to manage:

  • NBT and conventional production
  • Supply chain separation
  • Identity preservation

Timeline Projection

Optimistic Scenario

YearMilestone
2024-2025EU regulation adopted
2026-2027Member state implementation
2027-2028First grape variety approvals
2029-2030AOC/DOC amendments begin
2030-2035Limited commercial production

Conservative Scenario

Add 3-5 years to each milestone due to:

  • Political delays
  • Consumer campaigns
  • Technical challenges
  • Trade complications

Last Updated: January 7, 2026